cysteine has been researched along with Myasthenia Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bitzopoulou, K; Kostelidou, K; Poulas, K; Tzartos, SJ | 1 |
| Hara, S; Hideyuki, K; Mikami, A; Mori, T; Nakase, K; Sawa, N; Tachibana, S; Tagami, T; Takemoto, F; Ubara, Y; Yamada, A; Yokoyama, K | 1 |
2 other study(ies) available for cysteine and Myasthenia Gravis
| Article | Year |
|---|---|
Mutant forms of the extracellular domain of the human acetylcholine receptor gamma-subunit with improved solubility and enhanced antigenicity. The importance of the Cys-loop.
Topics: Amino Acid Sequence; Autoantibodies; Autoantigens; Base Sequence; Cysteine; DNA Primers; Glycosylation; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Myasthenia Gravis; Pichia; Polymerase Chain Reaction; Protein Structure, Tertiary; Protein Subunits; Receptors, Nicotinic; Recombinant Proteins; Sequence Homology, Amino Acid; Solubility | 2008 |
[A case of rheumatoid arthritis with bucillamine-induced myasthenia gravis treated by immunoadsorption therapy].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cysteine; Female; Humans; Immunosorbent Techniques; Middle Aged; Myasthenia Gravis | 1999 |